The FDA has cleared Neuronetrix's portable device for the recording of electrical brainwaves in patients with neurological conditions such as Alzheimer's disease, concussion, schizophrenia and ADHD.
The FDA has cleared Neuronetrix's portable device for the recording of electrical brainwaves in patients with neurological conditions such as Alzheimer's disease, concussion, schizophrenia and ADHD.
The device, called the Cognision System, is designed to run brainwave tests such as EEGs and auditory event-related potentials (ERPs). Neuronetrix said the device allows doctors to run tests in their offices that used to be only available in a hospital setting.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zBCQza
Cap comentari:
Publica un comentari a l'entrada